Insights on TALAPRO2 Trial and Future Implications for Prostate Cancer Treatment

This chapter covers the significant outcomes of the TALAPRO2 trial, revealing the effectiveness of talazoparib and enzalutamide in treating metastatic castrate-resistant prostate cancer. The discussion includes survival benefits, genetic mutation impacts on treatment, and future research directions while addressing toxicity and standard of care concerns.